AMA Ed Hub Logo

Get fast-track DEA training from AMA Ed Hub™
Red JAMA Logo

Learn more on substance use disorders from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on substance use disorders from PolicyFinder
Mature patient talking with psychotherapist in an office

Care for substance use disorder guide

Updated
| 3 Min Read
Clear Search
Naloxone spray
·
3 Min Read

Biden administration boosts access to overdose prevention, treatment

The drug-overdose epidemic continues during the COVID-19 pandemic, but steps are being taken that will save lives and enhance access to treatment.

Behavioral Health
·
3 Min Read

May 21, 2021: State Advocacy Update

Sterile needle and syringe exchange bill headed to Arizona governor and more in the latest State Advocacy Update.

Advocacy Update
Man in a mask, in a prison cell
·
5 Min Read

Why denying addiction treatment in jails, prisons is inhumane

Evidence shows medications to treat substance-use disorder treatment in jails and prisons are lifesaving, yet they’re too often denied. Learn more with the AMA.

Population Health
Pedestrians crossing the street
·
4 Min Read

Removing stigma, advancing evidence-based care at Mount Sinai

Learn about an innovative primary care program at the New York hospital that helps people with opioid-use disorder get the care they need.

Behavioral Health
·
1 Min Read

AMA statement on FDA decision on naloxone nasal

AMA commends FDA’s approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose.

Press Releases
·
4 Min Read

8 keys to end the nation’s drug-overdose epidemic

The CDC is reporting a record-breaking annual toll of nearly 90,000 U.S. overdose deaths. Learn about the policy steps needed to stem the tide.

Behavioral Health
Person in face mask looking out a window
·
3 Min Read

How this solo family practice integrates behavioral health care

This North Carolina family physician transformed her practice to meet the needs of patients struggling with substance-use disorder and mental health illness.

Behavioral Health
·
1 Min Read

AMA statement on HHS decision to remove addiction treatment barriers

AMA is pleased that HHS will support physicians to prescribe buprenorphine, will remove daunting regulatory barriers for patients with opioid use disorder.

Press Releases
·
3 Min Read

April 9, 2021: State Advocacy Update

Kentucky and Virginia enact opioid litigation abatement laws and more in the latest State Advocacy Update.

Advocacy Update